Home blood-analysis kits

01Overview and value chain

Markers: [EC: IVDR 2017/746 | OECD: Biotech-health | Regulator: FDA (USA), EMA (European Union), NMPA (China)]

Home blood-analysis kits let consumers collect their own blood sample — via finger-prick mail-in kit or a retail microsample draw — for laboratory testing outside a clinic visit, spanning general wellness panels to chronic-condition monitoring. LetsGetChecked and Everlywell both ship mail-in finger-prick kits covering a broad consumer test menu, with Everlywell’s product line spanning vitamin D and inflammation, cholesterol and lipids, heart health, food sensitivity and thyroid testing. Babson Diagnostics takes a different collection approach, drawing a microsample of blood at retail locations rather than through home self-collection; the company recently launched its BetterWay GLP-1 blood-testing panel at retail sites in Austin and Temple, Texas, expanding beyond its initial retail-partner launch, with trade press noting the parallel — and the technical differences — between microsample blood testing today and the earlier, discredited Theranos approach. In the UK, Thriva offers mail-in finger-prick blood test kits, competing in a UK market that also includes rivals such as Medichecks and Forth.

The key directions of home blood-analysis kits are:

1. Mail-in home blood test kits (Mail-In Home Blood Test Kits): finger-prick collection kits mailed to a certified laboratory, with results returned digitally — LetsGetChecked, Everlywell, Thriva.
2. Retail microsample blood testing (Retail Microsample Blood Testing): small-volume blood draws performed at a retail location rather than through home self-collection — Babson Diagnostics.
3. Consumer wellness panel menus (Consumer Wellness Panel Menus): broad test menus covering vitamins, lipids, thyroid, food sensitivity and general wellness markers — Everlywell’s product line.
4. Chronic-condition monitoring panels (Chronic-Condition Monitoring Panels): panels targeting a specific ongoing health-management use case, such as Babson’s GLP-1 blood-testing panel for weight-management drug monitoring.

Sectoral value chain

[kit/sample collection] ──> [sample transport to certified lab] ──> [lab analysis (CLIA-certified)]
                                                    │
                                       (digital result reporting)
                                                    │
                                                    ▼
[consumer/physician follow-up action] <─── [regulatory status] <─────┘

Value chain levels

Cross-cutting technologies of the sector:

• Finger-prick microsampling (Mail-In Home Blood Test Kits / Retail Microsample Blood Testing): small-volume capillary blood collection avoids a venous draw, enabling both home self-collection and quick retail-location sampling.
• Direct-to-consumer digital reporting (Consumer Wellness Panel Menus): results delivered through an app or web portal, often with plain-language interpretation, distinguish this category from a traditional physician-mediated lab-order workflow.
• Condition-specific monitoring panels (Chronic-Condition Monitoring Panels): test menus built around a specific ongoing management need, such as GLP-1 drug monitoring, extend the category beyond general wellness screening.

02US

The US anchors the deepest bench of home and retail blood-testing companies, spanning mail-in kits and a newer retail-microsample model.

LetsGetChecked, Everlywell, Babson Diagnostics, FDA

• LetsGetChecked: ships mail-in finger-prick kits covering a range of consumer health tests, including whole-blood nutrient and cholesterol panels.
• Everlywell: offers a broad mail-in test menu spanning vitamin D and inflammation, cholesterol and lipids, heart health, food sensitivity and thyroid testing.
• Babson Diagnostics: draws a microsample of blood at retail locations rather than through home self-collection, and recently launched its BetterWay GLP-1 blood-testing panel at retail sites in Austin and Temple, Texas.
• FDA framework: most home and retail blood-test panels operate as laboratory-developed tests (LDTs) under CLIA rather than as FDA-cleared diagnostic devices, with the underlying laboratory bearing responsibility for analytical validity.

03CN

No dedicated Chinese home blood-analysis kit company cleared source confirmation as of 2026; Chinese sources covering this period center on specific test-kit product categories (e.g. kidney-function or infectious-disease self-test kits) rather than a broad consumer home-blood-testing platform comparable to the Western players.

product-category coverage, NMPA pathway

• Product-category focus: Chinese market coverage of home test kits in this period addresses individual test categories rather than a multi-panel consumer blood-testing platform.
• NMPA pathway: any home blood-testing kit reaching Chinese consumers would register with NMPA as an in-vitro diagnostic product, following the same device-class pathway as other self-test kits.

04EU

The UK anchors Europe’s home blood-testing market through Thriva, competing alongside established rivals in a mature consumer category.

Thriva, IVDR

• Thriva: offers mail-in finger-prick blood test kits, competing in a UK market that also includes rivals such as Medichecks and Forth, reflecting an established, multi-player consumer category.
• IVDR framework: home blood-test kits sold in the EU require conformity assessment and CE marking under the In Vitro Diagnostic Regulation (IVDR 2017/746), with the underlying laboratory services subject to separate accreditation requirements.

05Leading companies and research institutes

06Tech stack and innovations

The stack pairs small-volume finger-prick or microsample collection with a CLIA-certified (or IVDR-governed) laboratory backend and a direct-to-consumer digital reporting layer, removing the clinic visit from the standard blood-testing workflow.

1. Mail-in finger-prick collection (Mail-In Home Blood Test Kits):
   • LetsGetChecked, Everlywell and Thriva all ship a self-collection kit the consumer uses at home, mailing the sample to a certified lab for analysis and receiving results digitally.
2. Retail microsample collection (Retail Microsample Blood Testing):
   • Babson Diagnostics draws a small blood sample at a retail location, an approach positioned between full home self-collection and a traditional clinic venous draw, expanded through its BetterWay retail rollout.
3. Broad consumer wellness menus (Consumer Wellness Panel Menus):
   • Everlywell’s test menu spans vitamins, lipids, thyroid function and food sensitivity, reflecting the category’s expansion beyond single-analyte tests into comprehensive wellness panels.
4. Condition-specific monitoring (Chronic-Condition Monitoring Panels):
   • Babson’s GLP-1 blood-testing panel targets a specific chronic-management use case (weight-management drug monitoring), illustrating the category’s extension from general wellness into targeted clinical-adjacent monitoring.

07Value chains and production pipelines

Industrial pipeline of a home/retail blood-test kit (CLIA LDT / EU IVDR 2017/746)

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Kit/sample collection  │ ───> │ 2. Sample transport to   │
│                            │      │    certified lab            │
└───────────────────────────┘      └───────────────────────────┘
                                                   │
                                                   ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Digital result         │ <─── │ 3. Lab analysis           │
│    reporting                │      │                           │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Regulatory status      │ ───> │ 6. Consumer/physician     │
│                            │      │    follow-up                │
└───────────────────────────┘      └───────────────────────────┘

Stage 1: Kit or sample collection

The consumer self-collects a finger-prick sample at home using a mailed kit (LetsGetChecked, Everlywell, Thriva), or a trained associate draws a microsample at a retail location (Babson Diagnostics).

Stage 2: Sample transport to certified lab

The collected sample is shipped or routed to a CLIA-certified (US) or accredited (EU) laboratory partner for processing.

Stage 3: Lab analysis

The laboratory runs the requested panel — nutrient, lipid, thyroid, GLP-1 or other markers — using standard clinical-laboratory analytical methods.

Stage 4: Digital result reporting

Results are delivered to the consumer through an app or web portal, typically with plain-language interpretive guidance alongside the raw values.

Stage 5: Regulatory status

Most panels operate as laboratory-developed tests (LDTs) under CLIA in the US, or as IVDR-governed laboratory services in the EU, with the underlying lab bearing responsibility for analytical validity rather than the kit itself requiring individual FDA device clearance.

Stage 6: Consumer or physician follow-up

The consumer adjusts diet, supplementation or lifestyle based on results within normal range, or consults a physician for results outside it, closing the loop from a self-collected sample to a health decision.